Home/Filings/4/0000899243-22-011727
4//SEC Filing

Kutok Jeffery 4

Accession 0000899243-22-011727

CIK 0001571498other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 6:05 PM ET

Size

5.4 KB

Accession

0000899243-22-011727

Insider Transaction Report

Form 4
Period: 2022-03-17
Kutok Jeffery
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-17+380,000380,000 total
    Exercise: $1.39Exp: 2032-03-16Common Stock (380,000 underlying)
Footnotes (1)
  • [F1]This option was granted on March 17, 2022 pursuant to the Company's 2013 Stock Incentive Plan with respect to 380,000 shares of Common Stock, with 25% vesting on March 17, 2023 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1
  • filerCIK 0001697644

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 6:05 PM ET
Size
5.4 KB